Coronavac: o que a ciência comprova

Abstract

Divided into eight chapters, the material includes research published in international publications such as The Lancet, The New England Journal of Medicine, Cell Discovery, Vaccine, Human Vaccines & Immunotherapeutics, Frontiers of Immunology, Cellular & Molecular Immunology and Future Oncology, among others. Each chapter has an abbreviated introduction in Portuguese or English and the complete original publications in English. The dossier brings topics such as the high immune response caused by CoronaVac, the vaccine's ability to combat SARS-CoV-2 variants, its safety for pregnant women, babies, children, young people, the elderly, people with comorbidities and immunosuppressed people, in addition to data about the importance of the booster dose and the safety records, which show the low incidence of adverse effects.